News & Blog
Latest from the Blog
-
January 14, 2021 NBTS Brain Tumor Clinical Trials Report: Q4 2020
It can be hard to keep track of new clinical trial opportunities opening across the United States, especially during the current public health crisis created by the coronavirus (COVID-19). However, there are many clinical trials still actively enrolling patients, and this report provides a summary of the studies that have recently opened or started for […]
Read more | -
January 7, 2021 New Treatment Arms Opening for Patients in NBTS-Funded GBM AGILE Clinical Trial
Yesterday, it was announced that the GBM AGILE adaptive clinical trial platform is opening two new treatment arms, with one evaluating Kintara Therapeutics’s chemotherapy, VAL-083, and Kazia Therapeutics’s targeted therapy, paxalisib. “NBTS has long supported GBM AGILE as a scientifically cutting-edge and more patient-friendly way to develop and evaluate emerging new treatments for patients,” says […]
Read more | -
December 19, 2020 4 Big Takeaways From the 2020 Annual Meeting of the Society for Neuro-Oncology
A move to a virtual platform didn’t diminish the quality of the 2020 Annual Meeting of the Society for Neuro-Oncology (SNO), the yearly gathering of the world’s foremost brain tumor researchers and clinicians. As usual, the National Brain Tumor Society was a proud platinum sponsor of this important conference and deployed our own team of […]
Read more |